Here are 18 key market players:
1. Arthrex
2. Cesca Therapeutics
3. DePuy Synthes
4. DMP Spine
5. Exactech
6. K2M
7. Lattice Biologics
8. Medtronic
9. Nuo Therapeutics
10. NuTech
11. NuVasive
12. Orthofix Holdings
13. Regen Lab SA
14. RTI Surgical
15. Stryker
16. Wright Medical Technology
17. Xtant Medical Holdings
18. Zimmer Biomet
More articles on biologics:
U of Missouri to release biojoint records amid allegations of false marketing: 5 things to know
Japan approves stem cell treatment for SCI — Some researchers doubt efficacy
Clinical trial proves stem cells effective to treat spinal cord injuries: 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
